免疫球蛋白G和补充剂作为多发性硬化症神经退行的主要参与者
Peter G E Kennedy1, Matthew Fultz2, Jeremiah Phares2
1Institute of Neuroscience and Psychology, University of Glasgow, Glasgow G61 1QH, UK.
Biomolecules
|October 26, 2024
概括
在多发性硬化症 (MS) 中,免疫球蛋白G (IgG) 抗体增加可能会触发补体激活,导致神经元损伤和神经退行. 这项研究揭示了MS病理学和潜在的治疗点.
科学领域:
- 神经免疫学 神经免疫学
- 中枢神经系统疾病 中枢神经系统疾病
- 脱线性疾病 脱线性疾病
背景情况:
- 多发性硬化症 (MS) 是年轻人的神经障碍的主要原因,其特点是中枢神经系统的炎症,脱髓化和神经退行.
- 轴突损失和神经元损伤是MS进展的关键驱动因素,但神经退行症的潜在机制仍然不明,阻碍了对渐进性MS的有效治疗开发.
- 多发性硬化症与中枢神经系统中免疫球蛋白水平升高和基克隆带有关,有证据表明补充剂在脱髓化中的作用.
研究的目的:
- 研究免疫球蛋白和补充蛋白在多发性硬化症 (MS) 神经退行性过程中的拟议作用.
- 阐明中枢神经系统IgG抗体增加导致神经元损伤和MS中脱髓化的机制.
主要方法:
- 这项研究提出了一种涉及IgG抗体和补充激活在MS神经退行症中的机制.
- 假设增加的中枢神经系统IgG抗体形成聚合物,结合补充C1q,并激活经典补充通路.
主要成果:
- 拟议的机制表明,激活补充剂导致神经元细胞损伤.
- 假设这种神经元损伤导致在MS中观察到的神经退行和脱髓化.
结论:
- 免疫球蛋白和补剂都涉及到作为MS神经退行性途径的积极参与者.
- 了解这种免疫球蛋白-补充相互作用可能会揭示进展性MS的新疗法策略.
相关概念视频
Complement System
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a membrane...
Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...


